Welcome To Spring Bank Pharmaceuticals

Latest News

- AUGUST 10, 2020
- 0
Spring Bank Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Results
Announced agreement for strategic combination with F-star Therapeutics to advance a pipeline of multiple clinical-stage immuno-oncology programs Continued to advance IV SB 11285 clinical trial to additional monotherapy and combination dosing cohorts Ab…
Read more

- JULY 29, 2020
- 0
Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies
Combined company will operate as F-star Therapeutics and advance pipeline of multiple clinical-stage immuno-oncology programs Combined company expected to have at least $40 million in cash prior to closing Spring Bank stockholders to receive two separa…
Read more

©2020 Spring Bank Pharmaceuticals. - Terms of Service, Privacy Policy, Disclaimer for Twitter , Disclaimer for LinkedIn